On July 1, 2008, Seattle Genetics, Inc. (the “Company”) entered into the Second Amendment to Lease (the “Second Amendment”) with B&N 141-302, LLC (“Landlord”) amending the Lease dated December 1, 2000 for the Company’s headquarters located in Bothell, WA (the “Lease”). The Company currently occupies and utilizes the entire building of approximately 63,900 square feet as laboratory, discovery, research and development and general administration space. The Second Amendment, among other items, extends the term of the Lease through June 2018 and provides for two renewal terms of five years. The Second Amendment will be filed as an exhibit to the Company’s quarterly report on Form 10-Q for the quarter ending September 30, 2008, with portions omitted and filed separately with the Securities and Exchange Commission pursuant to a request for confidential treatment.

The Company does not have any material relationship with Landlord or its affiliates other than:

“Safe Harbor” Statement under the Private Securities Litigation Reform Act of 1995: Statements in this report regarding the Company’s business that are not historical facts are “forward-looking statements” that involve risks and uncertainties. For a discussion of these risks and uncertainties, any of which could cause the Company’s actual results to differ from those contained in the forward-looking statement, see the section entitled “Risk Factors” in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and discussions of potential risks and uncertainties in the Company’s subsequent filings with the SEC.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.